Stocksigma LogoStocksigma Logo

CORONA Remedies Reports Q2 FY27 Consolidated Financial Results

CORONA Remedies reported a 22.16% YoY increase in consolidated revenue from operations to Rs 441.17 crore for the quarter ended 30th Sep'26, compared to Rs

CORONA Remedies Reports Q2 FY27 Consolidated Financial Results

Corona Remedies Ltd 路 Financial Result 路 31 Oct 2026, 12:12 am

CORONA Remedies Reports Q2 FY27 Consolidated Financial Results CORONA Remedies reported a 22.16% YoY increase in consolidated revenue from operations to Rs 441.17 crore for the quarter ended 30th Sep'26, compared to Rs 361.13 crore in the corresponding period last year. Consolidated net profit rose 15.27% YoY to Rs 60.31 crore from Rs 52.32 crore, delivering a basic and diluted EPS of Rs 9.86 versus Rs 8.55. For H1 ended 30th Sep'26, consolidated revenue grew 22.03% YoY to Rs 863.60 crore, while net profit advanced 22.23% YoY to Rs 120.42 crore.

Original exchange filing (PDF)

More announcements from Corona Remedies Ltd

All Corona Remedies Ltd announcements